Reduction in the severity and duration of headache following fremanezumab treatment in patients with episodic and chronic migraine

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • head.14127

    Final published version, 478 KB, PDF document

Original languageEnglish
JournalHeadache
Volume61
Issue number6
Pages (from-to)916-926
Number of pages11
ISSN0017-8748
DOIs
Publication statusPublished - 1 Jun 2021

ID: 280609368